Table 2.
Association of visceral adiposity indexes with the development of diabetic nephropathy and retinopathy
| Hazard ratio (95% CI) | ||||
|---|---|---|---|---|
| Model 1 | P value | Model 2 | P value | |
| Nephropathy | ||||
| VAI per-SD increase | 1.154 (1.095–1.217) | < 0.001 | 1.127 (1.050–1.210) | 0.001 |
| CVAI per-SD increase | 1.296 (1.159–1.450) | < 0.001 | 1.165 (1.003–1.353) | 0.045 |
| Retinopathy | ||||
| VAI per-SD increase | 0.739 (0.549–0.995) | 0.047 | 1.071 (0.950–1.207) | 0.264 |
| CVAI per-SD increase | 1.330 (1.038–1.704) | 0.024 | 0.878 (0.615–1.252) | 0.471 |
Model 1: adjusted for age and sex
Model 2: age, sex, BMI group, education level, smoking status, drinking status, physical activity, hypertension, dyslipidaemia, fasting glucose and use of antidiabetic medication
VAI visceral adiposity index, CVAI Chinese visceral adiposity index